Thermo Fisher Scientific Inc 2022 Investor Day Transcript
Good morning. I'm Rafael Tejada, Vice President of Investor Relations for Thermo Fisher Scientific, and I want to welcome you to our 2022 Investor Day.
I'm so happy to be back here in my hometown of New York City and to finally be able to see so many of you in person and finally be able to get a good decent bagel. So we have an amazing program for you today. So let me start by covering our agenda, and you'll see that come up momentarily on the screens.
We're going to start off with Marc Casper, our Chairman, President and Chief Executive Officer. He's going to start off with a strategic view of how we consistently create value for all of our stakeholders. We're then going to turn it over to Gianluca Pettiti, Executive Vice President, and he is going to discuss our approach to high-impact innovation. Michel Lagarde, our Executive Vice President and Chief Operating Officer, will then discuss our trusted partner status with pharma and biotech customers and provide an update on PPD. After a short break, Stephen Williamson, our CFO,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |